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Abstract
Background: Postprandial hyperglycemia is an early defect of type 2 diabetes and one of primary anti-diabetic
targets. Treatment of postprandial hyperglycemia can be achieved by inhibiting intestinal a-glucosidase, the key
enzyme for oligosaccharide digestion and further glucose absorption. Grape pomace is winemaking byproduct rich
in bioactive food compounds such as phenolic antioxidants. This study evaluated the anti-diabetic potential of two
specific grape pomace extracts by determining their antioxidant and anti-postprandial hyperglycemic activities
in vitro and in vivo.
Methods: The extracts of red wine grape pomace (Cabernet Franc) and white wine grape pomace (Chardonnay)
were prepared in 80% ethanol. An extract of red apple pomace was included as a comparison. The radical
scavenging activities and phenolic profiles of the pomace extracts were determined through the measurement of
oxygen radical absorbance capacity, DPPH radical scavenging activity, total phenolic content and flavonoids. The
inhibitory effects of the pomace extracts on yeast and rat intestinal a-glucosidases were determined. Male 6-week
old C57BLKS/6NCr mice were treated with streptozocin to induce diabetes. The diabetic mice were then treated
with vehicle or the grape pomace extract to determine whether the oral intake of the extract can suppress
postprandial hyperglycemia through the inhibition of intestinal a-glucosidases.
Results: The red grape pomace extract contained significantly higher amounts of flavonoids and phenolic
compounds and exerted stronger oxygen radical absorbance capacity than the red apple pomace extract. Both the
grape pomace extracts but not the apple pomace extract exerted significant inhibition on intestinal a-glucosidases
and the inhibition appears to be specific. In the animal study, the oral intake of the grape pomace extract
(400 mg/kg body weight) significantly suppressed the postprandial hyperglycemia by 35% in streptozocin-induced
diabetic mice following starch challenge.
Conclusion: This is the first report that the grape pomace extracts selectively and significantly inhibits intestinal
a-glucosidase and suppresses postprandial hyperglycemia in diabetic mice. The antioxidant and anti-postprandial
hyperglycemic activities demonstrated on the tested grape pomace extract therefore suggest a potential for
utilizing grape pomace-derived bioactive compounds in management of diabetes.
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The prevalence of diabetes has risen at an alarming rate.
Considering the heterogeneity of diabetes and the lim-
itations of current therapies, such as high secondary fail-
ure rates and significant side effects, there is an urgent
need to explore novel health-promotion and therapeuti-
cal strategies. One intriguing approach to control dia-
betes could be its prevention and treatment by
phytochemicals present in the diet that improve post-
prandial glycemic control and reduce postprandial
hyperglycemia [1-4]. Postprandial hyperglycemia is an
early detected symptom in type 2 diabetes [5], which
occurs when pancreatic b cells fail to secrete a sufficient
amount of insulin [6]. Emerging evidence suggests that
postprandial hyperglycemia induces glucose toxicity and
deteriorates b cell function [7], which can ultimately
result in an irreversible state of diabetes [8].
Postprandial hyperglycemia is related to the amount
and digestion rate of consumed starch, which is the pri-
mary source of blood glucose. One important approach
for treating postprandial hyperglycemia is to reduce or
slow dietary carbohydrate digestion and absorption
[9-11]. This approach can be achieved by inhibiting
starch hydrolyzing enzymes in the digestive system
[12-14]. Mammalian starch digestion primarily occurs in
the small intestine through the action of a-amylase,
yielding both linear maltose and branched isomaltose
oligosaccharides, which are further hydrolyzed by a-glu-
cosidases to release glucose [15]. Synthetic and naturally
derived compounds are known to reduce postprandial
hyperglycemia by inhibiting key carbohydrate metaboliz-
ing enzyme in the small intestine such as a-glucosidase
[16,17]. For example, phenolic compounds comprised in
plants have been found to be potent inhibitors of carbo-
hydrate hydrolyzing enzymes [18-21]. In a screening test
among more than 300 food extracts and compounds, we
identified a grape pomace extract exert significant inhi-
bition of a-glucosidases, suggesting its potential use for
diabetes management.
Grape pomace is rich in phenolic compounds but
typically regarded as a waste byproduct generated in the
lucrative winemaking industry [22]. Large amounts of
this byproduct accumulate annually which leads to a
waste-management issue [23]. It is estimated that the
harvested grapes will generate approximately 20% of
grape pomace. However, uses of grape pomace are lim-
ited but have been recycled as organic fertilizers, man-
ure, and animal feed. On the other hand, grapes are
known to be a natural source of notable bioactive com-
pounds in particular antioxidants with potential health
promoting and disease protective qualities [24-26]. For
example, wine, grapes, and grape seed extracts are a
major source of polyphenolic components such as
anthocyanins, flavanols, catechins, and proanthocyani-
dins [27-31]. Because grape skins and seeds are the pre-
dominant constituents in the pomace, this biomass is
speculated to be a rich source of antioxidants [32,33].
Dietary antioxidants have been associated with the
reduced risk of type 2 diabetes by inhibiting peroxida-
tion chain reactions. However, very few studies have
investigated the potential of grape pomace as an alterna-
tive bioresource for diabetes management [22,33-38].
The aim of this study was to evaluate anti-diabetic
potential of the grape pomace extracts by determining
their antioxidant and anti-postprandial hyperglycemic
activities. Two grape pomace extracts: one red wine grape
pomace (Cabernet Franc, RGPE) and one white wine
grape pomace (Chardonnay, WGPE) were investigated for
their total phenolic contents, total flavonoids, free radical
scavenging activities, and their inhibitory effects against
yeast and rat intestinal a-glucosidase. We also included an
extract of a red apple pomace (RAPE) for comparison
because the apple pomace is also rich in phenolic antioxi-
dants but its bioactivities may be different.
Methods
Materials
Yeast type I a-glucosidase (EC 3.2.1.20, G5003), rat
intestinal acetone powder (N1377-5G), p-nitrophenyl a-
D-glucoside (pNPG), acarbose, porcine pancreatic
a-amylase, type VI-B (A3176), porcine pancreatic lipase,
Type ll (L3216), Folin-Ciocalteu reagent, gallic acid,
rutin, Trolox™, fluorescein, 2,2’-Azobis(2-amidinopro-
pane) dihydrochloride (AAPH), 1,1-diphenyl-2-picrylhy-
drazyl (DPPH), and streptozotocin (STZ) were
purchased from the Sigma Chemical Co. (St. Louis, MO,
USA). The ethanol and acetone solvent was HPLC
grade (Fisher Scientific Co.).
Preparation of pomace extracts
R e dw i n eg r a p ep o m a c e( C a b e r n e tF r a n c )a n dw h i t e
wine grape pomace (Chardonnay) were obtained from a
local Virginia vineyard (Blackstone, VA, USA). The red
apple pomace was obtained from National fruit product
company, INC. (Winchester, VA). All the pomace
extracts were prepared from a single production lot. A
portion of the pomace samples (500 g) were immedi-
ately freeze-dried upon receiving. The dried extracts
were then ground to fine powder by a Thomas Wiley
mini-mill (Swedesboro, NJ). The samples were extracted
with 80% ethanol at 1:10 ratio (m/v) under overnight
shaking. The extracts were filtered through Whatman
No. 4 filter paper to remove unwanted residues. After
evaporating off the organic solvent, the filtrates were
frozen and lyophilized to obtain the pomace extracts.
The extraction yield was 13.4%, 16.3%, and 13.8% for
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respectively. A portion of the lyophilized extracts were
freshly reconstituted in dimethyl sulfoxide (DMSO) at
20 mg/mL as the stock solution and stored at -20°C for
further investigation.
Total phenolic content (TPC)
The TPC of each pomace extract was determined using
Folin-Ciocalteu reagent with gallic acid as the phenolic
standard [39]. In brief, appropriate dilutions of extracts
were mixed with 3.0 mL of 0.2 N Folin-Ciocalteu
reagent and 2.0 mL of 20% sodium carbonate (Na2CO3)
at ambient temperature. After incubation for 2 hours,
the absorbance of the blue color that developed in each
assay mixture was recorded at 760 nm (Thermo Elec-
tron Corporation, Genesys 10-UV scanning, Madison,
WI, USA). The TPC value of each pomace extract was
expressed as micrograms of gallic acid equivalent per
gram of pomace (μg GAE/g).
Total flavonoid content (TFC)
The pomace extracts were analyzed for TFC according
to an established colormetric method [40]. In brief, 1
mL of the reconstituted pomace extract (500 μg/mL) or
rutin standard was mixed with 0.3 mL of 5% sodium
nitrite (NaNO2), 0.3 mL of 10% aluminum chloride
(AlCl3), and 2 mL of 1 M sodium hydroxide (NaOH).
The reaction mixture was incubated at 30°C for 30 min.
All samples were measured in duplicate and compared
against a blank at an absorbance of 510 nm (Thermo
Electron Corporation, Genesys 10-UV scanning, Madi-
son, WI, USA). Results were expressed as micrograms
of rutin equivalent per gram of pomace (μg RE/g).
Oxygen radical absorbance capacity (ORAC)
The ORAC assay was conducted to kinetically measure
the peroxyl radical scavenging activity of each pomace
extract with Trolox™ as the antioxidant standard (Zhou
et al., 2007). Fluorescein (FL) was used as the fluores-
cent probe and the peroxyl radicals were generated from
AAPH in 75 mM phosphate buffer (pH 7.4). Specifically,
225 μL of 81.6 nM FL solution was mixed with 30 μLo f
sample extract, standard, or blank (DMSO) to a black
96-well fat bottom plate and incubate covered plate at
37°C for 20 min. After incubation, 25 μLo f0 . 3 6M
APPH solution was added to the mixture and the reac-
tion started. Standards and samples were measured in
duplicate. The fluorescence of the reaction mixture was
monitored and recorded every minute (lex = 485 nm
and lem = 535 nm) and maintained at 37°C until the
reading had declined to less than 5% of the initial read-
ing with a Victor
3 multilabel plate reader (Perkin-Elmer,
Turku, Finland). Results for ORAC were determined
by using a regression equation relating Trolox™
concentrations and the net area under the kinetic fluor-
escein decay curve. The ORAC value was expressed in
micromoles of Trolox™ equivalents per gram of pomace
(μmol TE/g).
DPPH radical scavenging activity
The DPPH radical scavenging antioxidant activity assay
was conducted to obtain the antioxidant activity of
pomace extracts [41]. The reaction mixture contained
100 μL of the diluted pomace extracts (1 mg/mL) and
100 μL of 0.208 mM DPPH radical solution. The
absorption at 515 nm was determined immediately after
the reaction was initiated. Each plate was read once
every minute for 30 min with a Victor
3 multilabel plate
reader. The initial and final absorbance for the control
was 0.934 and 0.917, respectively. The percent inhibition
of the DPPH radical scavenging activity per milligram of
pomace extract was expressed as the inhibition percen-
tage (% DPPH inhibition/mg).
Yeast and mammalian a-glucosidase inhibition assays
Both the yeast and mammalian a-glucosidase activity
was assayed using the substrate p-nitrophenyl-a-d-glu-
copyranoside (pNPG), which is hydrolyzed by a-glucosi-
dase to release the product p-nitrophenol, a color agent
that can be monitored at 405 nm [42]. The mammalian
a-glucosidases were prepared from 1 g of rat intestinal
acetone powder suspended in 20 mL of 0.1 M potassium
phosphate buffer (pH 7.0) containing 5 mM EDTA at
ambient temperature. The suspension was sonicated for
15 min and after vigorous stirring for 1 h, the suspen-
sion was centrifuged. The supernatant was dialyzed
against 0.01 M potassium phosphate buffer (pH 7.0) for
24 hours. The activity of rat a-glucosidase extract was
verified using pNPG as the substrate by comparing with
the pure yeast a-glucosidase. The assays were conducted
by mixing 80 μL of approximate dilutions of the pomace
extracts (10 μg/mL) in 0.1 M phosphate buffer (pH 6.8)
with 20 μL of the yeast enzyme solution (1 U/mL) or
20 μLr a ti n t e s t i n a la-glucosidase solution (3 × dilution
from the original extract). The acarbose (150 μg/mL)
was used as a positive control. The pH of the sample
extracts were 6.8 which was the optimal for the enzyme
reaction. The blank reagent, 0.1 M phosphate buffer
(pH 6.8), was used as the control. The mixture was
incubated in a 96-well plate at 37°C for 3 minutes under
constant shaking. After incubation, 100 μLo f4m M
pNPG solution in 0.1 M phosphate buffer (pH 6.8) was
added and the reaction was conducted at 37°C. The
release of p-nitrophenol from pNPG was monitored at
405 nm every minute for 75 minutes with a Victor
3
multilabel plate reader. The a-glucosidase activity was
determined by measuring the area under the curve
(0-75 minutes) for each sample and compared with that
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expressed as the percent of a-glucosidase inhibition.
Animal experiments
Animals
Male 6-week old mice (C57BLKS/6NCr, National
Cancer Institute, Frederick, MD, USA) were housed in
groups of four mice per cage and maintained on a
12-hour light-dark cycle at 20°C to 22°C. The animals
were acclimatized for a 2-week period before starting
the experiment and had ad libitum access to food and
water. The mice were maintained on rodent feed
(Harlan Tekland Gobal Diets 2018 rodent diet contain-
ing 60% of calories from carbohydrate, 23% of calories
from protein, and 17% of calories from fat; digestible
energy of 3.4 Kcal/g, Madison WI, USA) for the dura-
tion of the experiment. Animal husbandry, care, and
experimental procedures were conducted in compliance
with the “Principles of Laboratory Animal Care” NIH
guidelines, as approved by the Institutional Animal Care
and Use Committee (IACUC) at Virginia Tech.
STZ induction of diabetes in mice
Diabetes was induced in 14-hour fasted 8-week old mice
(25-27 g) by intraperitoneal injection of STZ dissolved
in 10 mM sodium citrate buffer (pH 4.5) at a dose of
50 mg/kg body weight (bw). The STZ was dissolved in
ice-cold citrate buffer protected from light and injected
immediately to avoid STZ degradation. Five to seven
days after STZ injection, mice with a fasting blood
glucose (FBG) level higher than 126 mg/dL were consid-
ered to have diabetes and were randomly assigned to
one of two groups (n = 8).
Oral RGPE treatment and starch challenge
The experiment was designed to determine the effect of
acute RGPE intake on postprandial glycemic response in
STZ-induced diabetic mice following a potato starch
challenge. Diabetic mice were fasted for 14-hours in
freshly cleaned cages with free access to water before
the experiment. Ten mg of the lyophilized RGPE was
suspended in 0.2 mL water (50 mg/mL) in a small cen-
trifuge tube and vortexed vigorously. The dietary dose
was calculated to be 400 mg/kg bw based on mouse
weight of 25 g. Mice in the control group were given
0.2 mL of water by oral gavage. The treatment group
were administered 0.2 mL of RGPE suspension (400
mg/kg bw) by oral gavage immediately after vortexing
the suspension. After approximately 30 minutes post
water or RGPE administration, 0.2 mL of potato starch
suspension (2 g/kg bw) was administered to each mouse
by gavage. Approximately 5 μL of whole blood samples
were collected from the tail vein of each mouse.
The blood samples were acquired at 0, 30, 60, and
120 minutes after the oral starch challenge. Blood glu-
cose levels were measured with a blood glucometer and
accompanying test strips (ACCU-CHEK Meter®, Roche
Diagnostics, Kalamazoo, MI). The area under the
glucose tolerance curve (AUC0-120 min) was calculated
using a trapezoidal method [43]. The total antihypergly-
cemic response (AUC0-120 min) was expressed as mean ±
standard deviation.
Statistical analysis
The statistical significance comparing data between
groups was assessed by one-way analysis of variance
(ANOVA) followed by Duncan’s multiple range post-
hoc tests. Statistical analysis was performed using SPSS
(Windows, Version Rel. 10.0.5, 1999, SPSS Inc., Chicago,
IL). Statistical significance was declared when P < 0.05.
Results
TPC and TFC in the pomace extracts
As shown in Table 1, all the three tested pomace sam-
ples contained noticeable amount of phenolic and flavo-
noid compounds. The RGPE contained the highest TPC
(30.4 mg GAE/g) followed by the WGPE (24.5 mg GAE/
g), while the red apple pomace extract (RAPE) con-
tained the least TPC (11.2 mg GAE/g). In a similar
trend, the RGPE contained the highest TFC (22.1 mg
RE/g), followed by the WGPE (16.2 mg RE/g) and the
RAPE (5.7 mg RE/g). The RGPE contained significantly
higher TPC and TFC than the RAPE. Flavonoids
account for 72% and 66% of total phenolic compounds
in the RGPE and WGPE, respectively. However, in the
RAPE, only approximately 50% phenolic compounds are
flavonoids, suggesting that the profile of phenolic com-
pounds between grape and apple pomaces could be
remarkably different.
ORAC and DPPH radical scavenging activities of the
pomace extracts
The ORAC assay measured the scavenging capacity of
pomace extracts against peroxyl radicals. As shown in
Table 1, the RGPE exerted the highest ORAC value
(245.0 μmol TE/g) as compared to either the WGPE
(198.3 μm o lT E / g )o rt h eR A P E( 1 6 8 . 8μmol TE/g, P <
0.05). One milligram of the RGPE, WGPE, and the
RAPE quenched 66%, 67%, and 55% of DPPH radicals
in the reaction, respectively. However, no statistical dif-
ferences were detected between any of the three tested
pomace extracts.
In vitro yeast and rat intestinal a-glucosidase inhibition
by the pomace extracts
Yeast a-glucosidase is readily available in a pure form
and has been widely used for anti-diabetes nutraceutical
and medicinal investigations as a model for screening
potential inhibitors [13,20,42,44-46]. Figure 1A reveals
the time-responses of the pomace extracts (10 μg/mL)
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significantly inhibited the enzyme activity and the inhi-
bition was sustained during 75 minutes of the incuba-
tion. However, the RAPE showed no inhibition on yeast
a-glucosidase, suggesting grape pomaces contain unique
a-glucosidase inhibitory compounds. Interestingly, both
the RGPE and WGPE showed stronger a-glucosidase
inhibitory activity than acarbose, a commercial a-gluco-
sidase inhibitor. As showni nF i g u r e1 B ,t h eR G P Ea n d
WGPE both at 10 μg/mL inhibited yeast a-glucosidase
activity by 63.9% and 42.4%, respectively; while acarbose
at 150 μg/mL only inhibited the enzyme activity
by 26.5%.
Figure 2 shows the effects of the pomace extracts on
rat intestinal a-glucosidase, both RGPE and WGPE at
1.5 mg/mL in the reaction mixtures exerted significant
inhibitory activity on the enzyme. The RGPE inhibited
the enzyme activity by 47% and the inhibition potency
was significantly higher than the WGPE which inhibited
Table 1 Total phenolic content, total flavonoid content, ORAC, and DPPH of the pomace extracts
Red grape pomace White grape pomace Red Apple pomace
Total phenolic content (mg GAE/g) 30.4 ± 11.0
a 24.5 ± 6.0
a,b 11.2 ± 5.9
b
Total flavonoid content (mg RE/g) 22.1 ± 8.9
a 16.2 ± 5.4
a,b 5.7 ± 4.7
b
ORAC (μmol TE/g) 245.3 ± 21.0
a 197.7 ± 25.5
b 168.8 ± 22.7
b
%DPPH Inhibition/mg 66.1 ± 0.6 67.4 ± 4.1 54.6 ± 13.2
Total phenolic content is expressed as μg of gallic acid equivalents (GAE) per gram of pomace; total flavonoid content is expressed as μg of rutin equivalents
(RE) per gram of pomace. Oxygen radical absorbance capacity (ORAC) was measured in triplicate, values expressed as micromoles Trolox equivalents per gram of
pomace (μmol TE/g). The DPPH radical scavenging activity was expressed as percent inhibition of DPPH free radical per mg of pomace. For each measurement,
the data marked by different letters for each assay are significantly different (P < 0.05).
Figure 1 The inhibitory effects of the grape and apple pomace
extracts on yeast a-glucosidase activity: A. Time responses of
the pomace extracts on the enzyme activity; B. Comparison of
the inhibitory activities by the different pomace extracts.
Acarbose (150 μg/mL), is a commercially available oral alpha-
glucosidase inhibitor which served as the positive control. The
a-glucosidase activity was determined by measuring p-nitrophenol
released from pNPG at 405 nm. The reaction was conducted at 37°C
for 75 minutes. Results are expressed as mean ± standard deviation.
* significant difference versus the control (P < 0.05).
Figure 2 The inhibitory effects of the grape and apple pomace
extracts on rat intestinal a-glucosidase activity. The a-
glucosidase extract was prepared from rat intestinal powder. The
enzyme activity was determined by measuring p-nitrophenol
released from pNPG at 405 nm. The reaction was conducted at 37°C
for 75 minutes. Results are expressed as mean ± standard deviation.
Bars with different letters are significantly different (P < 0.05).
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son, the RAPE at 1.5 mg/mL did not exert any effect on
rat a-glucosidase while acarbose at 0.5 mg/mL inhibited
the enzyme by 73%. A dose-dependent inhibition of rat
intestinal a-glucosidase by the RGPE was observed in
the reaction with concentrations ranging from 0-2.5 mg/
mL (Figure 3). The RGPE inhibited over 64% of the rat
a-glucosidase activity at a concentration of 2.5 mg/mL.
The IC50 of the RGPE were determined as 1.63 mg/mL.
Inhibition of postprandial hyperglycemia by the acute
intake of RGPE in STZ-induced diabetic mice
The oral administration of the RGPE (400 mg/kg bw)
suppressed postprandial hyperglycemia in STZ-induced
mice after the starch challenge (2 g/kg bw) (Figure 4A).
After extrapolation of the data using the area under the
curve (AUC), the overall percent glucose suppression
between the control and RGPE administered groups was
determined. The RGPE group had a significant 35%
reduction in the glucose AUC0-120 min compared to the
control group (P < 0.05) (Figure 4B).
Discussion
Phenolic content and antioxidant properties of the
pomace extracts
Phenolic compounds have been recognized as important
natural antioxidants rich in many kinds of foods and
plants. Apple and grape pomace also contain significant
but remarkably varied amounts of phenolic compounds
[35,47]. Similar to previous pomace antioxidant reports
[48,49], the grape and apple pomace extracts in our
study exerted significant peroxyl radical (ORAC) and
DPPH radical scavenging activities. In our experiments,
all the pomace samples were extracted and prepared
under the same conditions. We detected that the RGPE
exerted the highest TPC and ORAC among the tested
pomace extracts, suggesting the RGPE is one of the bet-
ter pomace resource of natural antioxidants.
In vitro yeast and rat intestinal a-glucosidase inhibition
by the pomace extracts
Yeast a-glucosidase is readily available in a pure form
and has been widely used for anti-diabetes nutraceutical
and medicinal investigations as a model for screening
potential inhibitors [13,20,42,44-46]. We showed that
Figure 3 Dose-dependent inhibition of rat intestinal a-
glucosidase activity by RGPE. The RGPE was tested with
concentrations ranging from 0 to 2.5 mg/mL. Results are expressed
as mean ± standard deviation.
Figure 4 The inhibitory effect of the RGPE oral intake on
postprandial hyperglycemia in STZ-induced diabetic mice after
starch challenge. The fasted STZ-induced diabetic mice were
administered with 100 μL of either vehicle or RGPE solution (400 mg/
kg, bw) by gavage. After approximately 15 min, 100 μL of potato
starch solution (2 g/kg, bw) was administered and blood was
collected from tail vein at 0, 30, 60, and 120 min to determine blood
glucose levels. A. The glycemic response curve in diabetic mice after
starch challenge. B. The incremental AUC0-120 min in diabetic mice
after starch administration. *, P < 0.05 vs. control (n = 8).
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pomace extract significantly inhibited yeast a-glucosi-
dase and their inhibitory activity were stronger than
acarbose, the commercial a-glucosidase inhibitor (Figure
1). It is known that a-glucosidase is sensitive to the pH
and the pH of the sample extracts may affect the
enzyme activity. In this study, the pomace extracts were
diluted from the stock 20 mg/mL DMSO solution with
0.1 M phosphate buffer (pH 6.8) and the dilution factor
was more than 1000 fold, thereby eliminating the possi-
ble effect of the sample pH. Therefore, the significant
inhibitory effects of RGPE and WGPE on a-glucosidase
are attributable to the unique compounds contained in
the extracts.
To determine whether the inhibition is specific, we
further evaluated the effects of the RGPE and WGPE on
other digestive enzymes including pancreatic a-amylase
and lipase. However, both the RGPE and WGPE showed
no significant inhibition on the two digestive enzymes
(data not shown). Both a-amylase (E.C. 3.2.1.1) and a-
glucosidase (EC 3.2.1.20) belong to the glycoside hydro-
lase family 13 and share a common reaction mechanism
and several short conserved sequences [50]. Non-specific
inhibitors often inhibit both enzymes due to their struc-
tural similarities. However, our results showed that the
grape pomace extracts (both the WGPE and RGPE) sig-
nificantly inhibited a-glucosidase but not a-amylase,
suggesting that they are likely specifically targeting a-
glucosidases and their inhibiting mechanism may differ
from that of acarbose, which inhibits both a-amylase
and a-glucosidase. Acarbose has been used for diabetes
treatment but this agent has been problematic due to
associated adverse gastrointestinal (GI) side effects as a
result of its non-specific inhibition of a-amylase, causing
excessive accumulation of undigested carbohydrates in
the large intestine [3], [51]. Therefore, specific a-gluco-
sidase inhibitors may provide a novel antidiabetic effect
and at the same time fewer GI side effects than cur-
rently available inhibitors. As such, grape pomace
extracts that can specifically inhibit a-glucosidases may
have utility for diabetes management with reduced side
effects.
It should be noted that although yeast a-glucosidase
has been commonly used for anti-diabetic nutraceutical
and medicinal investigations, it is not biologically rele-
vant to the mammalian a-glucosidases. In an effort to
further establish the effectiveness of the RGPE and
WGPE on mammalian a-glucosidase, we further carried
out the enzyme inhibition tests using the mammalian a-
glucosidases prepared from rat intestinal acetone pow-
der. Indeed, both the grape pomace extracts significantly
inhibited rat intestinal a-glucosidase (Figure 2). The
RGPE exerted stronger inhibitory activity than the
WGPE and the trend was consistent with the results
detected from the yeast a-glucosidase assay (Figure 1B).
The IC50 of the RGPE was further determined to be
1.63 mg/mL which was comparable to other natural
a-glucosidase inhibitors such as oolong tea extract
(IC50 = 1.34 mg/mL) and green tea extract (IC50 =
0.735 mg/mL) [52]. Oral administration of the green tea
extract (300 mg/kg bw for 4 weeks) was found to signifi-
cantly reduced fasting blood glucose (by 54%) in STZ-
induced diabetic rats [53]. Our results revealed that the
grape pomace extracts were more effective in inhibiting
yeast a-glucosidase than rat intestinal a-glucosidases.
This could be because the extracts selectively inhibit
specific a-glucosidases instead of all the enzymes, so the
unaffected a-glucosidases in the complex can still
hydrolyze pNPG to develop color. Thus, to better
understand the inhibition of GSE on mammalian a-glu-
cosidases, further research is needed to assess the inhi-
biting action of RGPE on specific rat a-glucosidases.
Inhibition of postprandial hyperglycemia by the acute
intake of RGPE in STZ-induced diabetic mice
The potent in vitro inhibition of intestinal a-glucosidase
by RGPE prompted us to assess whether RGPE can also
inhibit a-glucosidase in vivo, limit or delay starch diges-
tion and absorption, and subsequently reduce postpran-
dial glycemic response. We induced diabetes in 6-8
week old male C57BL/6J mice by STZ through intraper-
itoneal injection. The diabetic mice were fasted and
orally gavaged with the RGPE solution followed by a
potato starch meal. The acute intake of the RGPE sup-
pressed the postprandial blood glucose AUC0-120 min in
STZ-induced diabetic mice by 35% (P < 0.05) (Figure
4B). Although the inhibiting effect of the RGPE intake
did not achieve statistical significance in the tested indi-
vidual time points, there was a noticeable trend indicat-
ing the potential glucose lowering effect of the RGPE as
compared to the control group. The mechanism by
which these results evolved are proposed to be a conse-
quence of RGPE inhibiting the metabolism of carbohy-
drates by the inhibition of brush border a-glucosidase
in the small intestine, similar to that of acarbose [54].
B a s e do nt h er e s u l t so b t a i n e dw i t hi n t e s t i n a la l p h a - g l u -
cosidase, it should be expected that in vivo acarbose is
m o r ee f f e c t i v et h e nR G P Ei nr e d u c i n gp o s t p r a n d i a l
hyperglycemia. Nevertheless, the in vivo results suggest
that the RGPE may exert potential anti-diabetic effect
by suppressing postprandial blood glucose through the
novel inhibition of intestinal a-glucosidase.
Conclusion
To our knowledge, this was the first report that the
grape pomace extract exerted significant anti-postpran-
dial hyperglycemic effect, suggesting that grape pomace
could be a valuable food derived bioresource that is rich
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Page 7 of 9in antioxidants and anti-hyperglycemic compounds.
These dual bioactive attributes derived from the grape
pomace could play a complementary and alternative role
in managing the poorly regulated blood glucose levels
and oxidative stress associated with Type 2 diabetes.
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